Role of patient-derived models of cancer in translational oncology

KF Idrisova, HU Simon, MO Gomzikova - Cancers, 2022 - mdpi.com
Simple Summary It was found that long-established tumor-derived cell lines do not
adequately reproduce drug sensitivity and behavior of a real human cancers. Therefore …

The CAM model—Q&A with experts

D Fischer, G Fluegen, P Garcia… - Cancers, 2022 - mdpi.com
Simple Summary The chorioallantoic membrane (CAM) model is an alternative in vivo test
system for the study of hallmarks of cancer such as angiogenesis, tumor growth, immune …

Future of Mesoporous Silica Nanoparticles in Nanomedicine: Protocol for Reproducible Synthesis, Characterization, Lipid Coating, and Loading of Therapeutics …

A Noureddine, A Maestas-Olguin, L Tang… - 2023 - ACS Publications
Owing to their uniform and tunable particle size, pore size, and shape, along with their
modular surface chemistry and biocompatibility, mesoporous silica nanoparticles (MSNs) …

[HTML][HTML] Applications of the chick chorioallantoic membrane as an alternative model for cancer studies

PY Chu, APF Koh, J Antony, RYJ Huang - Cells Tissues Organs, 2022 - karger.com
A variety of in vivo experimental models have been established for the studies of human
cancer using both cancer cell lines and patient-derived xenografts (PDXs). In order to meet …

Understanding and modeling metastasis biology to improve therapeutic strategies for combating osteosarcoma progression

TM Fan, RD Roberts, MM Lizardo - Frontiers in oncology, 2020 - frontiersin.org
Osteosarcoma is a malignant primary tumor of bone, arising from transformed progenitor
cells with osteoblastic differentiation and osteoid production. While categorized as a rare …

[HTML][HTML] A patient-derived cell atlas informs precision targeting of glioblastoma

P Johansson, C Krona, S Kundu, M Doroszko… - Cell reports, 2020 - cell.com
Glioblastoma (GBM) is a malignant brain tumor with few therapeutic options. The disease
presents with a complex spectrum of genomic aberrations, but the pharmacological …

Bridging the In Vitro to In Vivo gap: Using the Chick Embryo Model to Accelerate Nanoparticle Validation and Qualification for In Vivo studies

KS Butler, CJ Brinker, HS Leong - ACS nano, 2022 - ACS Publications
We postulate that nanoparticles (NPs) for use in therapeutic applications have largely not
realized their clinical potential due to an overall inability to use in vitro results to predict NP …

Tumor grafted–chick chorioallantoic membrane as an alternative model for biological cancer research and conventional/nanomaterial-based theranostics evaluation

AK Mapanao, PP Che, P Sarogni, P Sminia… - Expert Opinion on …, 2021 - Taylor & Francis
Introduction: Advancements in cancer management and treatment are associated with
strong preclinical research data, in which reliable cancer models are demanded. Indeed …

The CAM assay as an alternative in vivo model for drug testing

R Schneider-Stock, D Ribatti - Organotypic Models in Drug Development, 2021 - Springer
In the last decade, the chicken chorioallantoic membrane (CAM) assay has been re-
discovered in cancer research to study the molecular mechanisms of anti-cancer drug …

In ovo model in cancer research and tumor immunology

L Miebach, J Berner, S Bekeschus - Frontiers in Immunology, 2022 - frontiersin.org
Considering cancer not only as malignant cells on their own but as a complex disease in
which tumor cells interact and communicate with their microenvironment has motivated the …